Short Interest in ReShape Lifesciences Inc. (NASDAQ:RSLS) Declines By 38.1%

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the target of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 18,500 shares, a decline of 38.1% from the December 31st total of 29,900 shares. Based on an average daily volume of 84,300 shares, the short-interest ratio is currently 0.2 days. Approximately 2.7% of the company’s shares are sold short.

ReShape Lifesciences Price Performance

Shares of RSLS stock traded up $0.18 during mid-day trading on Wednesday, reaching $3.83. The stock had a trading volume of 50,814 shares, compared to its average volume of 27,466. ReShape Lifesciences has a 52-week low of $3.50 and a 52-week high of $29.00. The stock’s 50-day moving average price is $4.82 and its two-hundred day moving average price is $6.97.

ReShape Lifesciences Company Profile

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.